Johnson & Johnson (JNJ) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Drug Manufacturers - General industria. La empresa tiene su sede en New Brunswick, NJ, United States. El CEO actual es Joaquin Duato.
JNJ tiene fecha de IPO 1943-01-02, 138,100 empleados a tiempo completo, cotiza en el NYSE, una capitalización de mercado de $578.62B.
Johnson & Johnson is a global healthcare company focused on innovative pharmaceuticals and medical devices following its 2023 strategic separation of its consumer health business into Kenvue Inc. The company's Innovative Medicine segment develops prescription medications for complex diseases including rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders. Its MedTech segment provides advanced medical technology solutions spanning electrophysiology, neurovascular care, orthopedic implants, surgical systems, and ACUVUE contact lenses. Operating worldwide and headquartered in New Brunswick, New Jersey, Johnson & Johnson serves hospitals, healthcare professionals, wholesalers, and retailers while maintaining its mission of advancing human health since 1886.
